Systemic administration of glutaminase inhibitors suppressed the growth of RCC cells as xenografts in mice [54], while recent studies have shown that modulation of HIF-1α phosphorylation can regulate LD accumulation and cancer cell growth, specifically under hypoxia [64,80]. Here, HIF1A is linked to cancer.